The dual burdens of obesity and diabetes — both of which are direct antecedents to nonalcoholic fatty liver disease — have changed the map of fatty liver disease on a global basis.
Favorable results should prompt reconsideration of the value — health wise and economic — of oral nutritional supplementation in patients admitted for COPD.
